Internal medicine

Retrospective cohort study

Cohort study

Population

Ibuprofen

Antipyretic

Analgesic

Cohort

Anesthesia

Medicine

Pharmacology

Environmental health

Clinical Microbiology and Infection

It was recently suggested that ibuprofen might increase the risk for severe and fatal coronavirus disease 2019 (COVID-19) and should therefore be avoided in this patient population. We aimed to evaluate whether ibuprofen use in individuals with COVID-19 was associated with more severe disease, compared with individuals using paracetamol or no antipyretics.

Ibuprofen use and clinical outcomes in COVID-19 patients